Acadian Asset Management’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $198K | Buy |
139,723
+112,048
| +405% | +$159K | ﹤0.01% | 1309 |
|
|
2025
Q1 | $43K | Buy |
+27,675
| New | +$43K | ﹤0.01% | 1457 |
|
|
2024
Q3 | – | Sell |
-113,436
| Closed | -$524K | – | 2101 |
|
|
2024
Q2 | $524K | Buy |
113,436
+91,443
| +416% | +$422K | ﹤0.01% | 1184 |
|
|
2024
Q1 | $179K | Sell |
21,993
-147,423
| -87% | -$1.2M | ﹤0.01% | 1200 |
|
|
2023
Q4 | $956K | Buy |
169,416
+141,402
| +505% | +$798K | ﹤0.01% | 871 |
|
|
2023
Q3 | $51K | Sell |
28,014
-100,046
| -78% | -$182K | ﹤0.01% | 1428 |
|
|
2023
Q2 | $351K | Buy |
+128,060
| New | +$351K | ﹤0.01% | 1139 |
|